Example: Heart Attack

Search clinical trials for: Dose decrease

Total 7785 results

NCT01216332

Completed

Standard Versus High-Dose Trivalent Inactivated Flu Vaccine in Pediatric Acute Lymphoblastic Leukemia Patients

Pediatric Patients With Acute Lymphoblastic Leukemia
NCT02290093

Completed

Bowel Preparation for Colonoscopy in the Elderly

Colonoscopy | Bowel Preparation
NCT01670357

Completed

Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome (DES)

Dry Eye Syndrome
NCT02216825

Completed

Effect of L. Reuteri NCIMB 30242 on Plasma Bile Acid Profile

Hypercholesterolemia
NCT01610895

Unknown

Split Dose Polyethylene Glycol (PEG) + Clear Fluids Versus Split Dose PEG + Low-Residue Diet (BP)

Colorectal Cancer
NCT04741815

Completed

Effects of Different Warming Methods in Laparoscopic Cholecystectomy Surgery

Inadvertent Perioperative Hypothermia
NCT00573781

Completed

Dietary Modulation of Gene Expression and Metabolic Pathways in Glucose Metabolism (Sysdimet)

Obesity | Metabolic Syndrome | Impaired Glucose Tolerance | Impaired Fasting Glucose
NCT07286747

Recruiting

Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT) (CONCEPT)

Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
NCT06667999

Recruiting

The Intensive Care Platform Trial (INCEPT)

Critical Illness | Intensive Care Unit Patients | Intensive Care Patients
NCT03988933

Completed

2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB. (2R2)

Latent Tuberculosis
NCT05630859

Completed

Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age.

Sexually Transmitted Diseases
NCT02732262

Completed

Optimal Dose of i.v Oxycodone for Postoperative Pain

Pain
NCT02170909

Completed

Safety, Pharmacokinetics and Pharmacodynamics of BIBR 1048 MS Capsule in Healthy Male Subjects of Japanese and Caucasian Origin

Healthy
NCT01607450

Completed

Modulation of Human Myocardial Metabolism by GLP-1 Dose Response

Healthy | Type 2 Diabetes Mellitus
NCT02187497

Completed

Pharmacokinetics of BIBR 277 in Hypertensive Patients

Hypertension
NCT01604057

Unknown

Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass

Osteoporosis | Osteopenia
NCT07326878

Not yet recruiting

Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine

Hand, Foot and Mouth Disease | Hand, Foot and Mouth Disease (HFMD) | HFMD
NCT06975319

Active, not recruiting

Phase I Study With V-212 Vaccinations in Healthy Adult Volunteers

Healthy | Immunisation Against Streptococcus Pneumoniae
NCT05165966

Completed

Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19

COVID-19
NCT01862120

Completed

Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes (DFIL2-Child)

Type 1 Diabetes
NCT02216656

Completed

Phase 2 Study of KHK7580

Secondary Hyperparathyroidism
NCT02229773

Completed

Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 1464 (Tablet) in Hyperlipemic Healthy Male Subjects

Healthy
NCT02919605

Completed

Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis

Cutaneous Leishmaniases
NCT07502820

Not yet recruiting

The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER (POWER)

Breast Cancer | Adjuvant Drug Therapy
NCT07337876

Recruiting

Organ Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy (MARS)

Rectal Cancer
NCT07294950

Recruiting

Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination (REST)

Appetite Regulation | Weight Change | Obesity (Disorder) | Blood Pressure Monitoring
NCT07210502

Not yet recruiting

Side Effects of Low Dose Rate Brachytherapy and Ultra-hypofractionated Radiotherapy in Low to Intermediate Risk Prostate Cancer (LDR BURST)

Prostate Adenocarcinoma
NCT07029217

Recruiting

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

Follicular Lymphoma | Marginal Zone Lymphoma
NCT03417336

Recruiting

Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized Risk (SHORT)

To Evaluate the Rate of Digestive and Urinary Toxicity
NCT06020443

Active, not recruiting

Adherence to Lung Cancer Screening by Low-dose Thoracic CT in Haut-Rhin Department, France. (DECANPHAR)

Lung Cancer | High-Risk Cancer
NCT05562271

Completed

Clinical Trial of Low-dose Radiation Therapy in Patients With Knee Osteoarthritis (LoRD-KNeA Trial) (LoRD-KNeA)

Knee Osteoarthritis
NCT03581136

Active, not recruiting

Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod

Breast Cancer
NCT02921581

Completed

ReIrradiation with FDG-PET Guided Dose Painting (RIDPAINT)

Head and Neck Cancer
NCT04910308

Active, not recruiting

RAdiotherapy With FDG-PET Guided Dose-PAINTing for Primary Head and Neck (RADPAINT-2)

Head and Neck Cancer
NCT05552183

Completed

Study to Evaluate the Safety, Tolerability, and PK of Pacritinib

Hepatic Impairment
NCT05483725

Active, not recruiting

Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.

COVID-19 | Kidney Diseases | Vaccine Adverse Reaction | Kidney Transplant; Complications | Rejection Acute Renal | Rejection Chronic Renal
NCT03972501

Completed

An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD)

Meibomian Gland Dysfunction (MGD) | Contact Lens Discomfort (CLD)
NCT03897946

Completed

Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC

Hepatitis B
NCT03598517

Unknown

High Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer
NCT01594242

Completed

Autophagy Induction After Bortezomib for Myeloma

Multiple Myeloma
NCT00875485

Completed

Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™

Hepatitis B | Hepatitis A
NCT01842074

Unknown

Desensitization With Bortezomib Before a Living Kidney Donation (VELDON)

Patients Awaiting a Living Kidney Donation
NCT02366741

Unknown

Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot Study

Carcinoma, Small Cell
NCT01406509

Completed

Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Children

Healthy
NCT01286961

Completed

The Interval Between the Time of Second PEG Dose and the Start of the Colonoscopy (TOSP)

The Timing of Bowel Preparation in Outpatient Colonoscopy
NCT00496743

Terminated

Study of Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides

Mycosis Fungoides
NCT06519604

Active, not recruiting

Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese Males

Diabete Mellitus
NCT03233217

Completed

Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years

Influenza
NCT02387294

Completed

Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents

Human Influenza
NCT01997632

Completed

Phase 1 Study on the Safety and Reactogenicity of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) Given Intramuscularly Compared to Standard Trivalent Inactivated Poliovirus Vaccine (IPV) in Healthy Adults (IPV-004)

Poliomyelitis

Search clinical trials for: Dose decrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations